Autosomal dominant spastic paraplegia type 12 (Q100883): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Paraplegia espástica autossômica dominante causada pela expansão de repetição CAG não codificante no gene PPP2R2B, que codifica a proteína fosfatase 2. É caracterizada pelo início da infância até a idade adulta de espasticidade lentamente progressiva dos membros inferiores e hiperreflexia das extremidades inferiores, reflexos extensores plantares, comprometimento sensorial distal , disfunção urinária variável e pé cavo.
description / endescription / en
 
Autosomal dominant spastic paraplegia caused by non-coding CAG repeat expansion in the PPP2R2B gene coding for protein phosphatase 2. It is characterized by childhood to adulthood-onset of slowly progressive lower limb spasticity and hyperreflexia of lower extremities, extensor plantar reflexes, distal sensory impairment, variable urinary dysfunction and pes cavus.

Revision as of 17:39, 16 August 2026

Autosomal dominant spastic paraplegia caused by non-coding CAG repeat expansion in the PPP2R2B gene coding for protein phosphatase 2. It is characterized by childhood to adulthood-onset of slowly progressive lower limb spasticity and hyperreflexia of lower extremities, extensor plantar reflexes, distal sensory impairment, variable urinary dysfunction and pes cavus.
Language Label Description Also known as
default for all languages
ID_598149528
    English
    Autosomal dominant spastic paraplegia type 12
    Autosomal dominant spastic paraplegia caused by non-coding CAG repeat expansion in the PPP2R2B gene coding for protein phosphatase 2. It is characterized by childhood to adulthood-onset of slowly progressive lower limb spasticity and hyperreflexia of lower extremities, extensor plantar reflexes, distal sensory impairment, variable urinary dysfunction and pes cavus.

      Statements